Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
14.10
-0.07 (-0.53%)
Aug 11, 2025, 1:52 PM - Market open
Paramount Global Employees
As of August 31, 2024, Simulations Plus had 247 total employees, including 243 full-time and 4 part-time employees. The number of employees increased by 50 or 25.38% compared to the previous year.
Employees
247
Change (1Y)
50
Growth (1Y)
25.38%
Revenue / Employee
$325,437
Profits / Employee
-$255,846
Market Cap
283.69M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 247 | 50 | 25.38% |
| Aug 31, 2023 | 197 | 34 | 20.86% |
| Aug 31, 2022 | 163 | 17 | 11.64% |
| Aug 31, 2021 | 146 | 9 | 6.57% |
| Aug 31, 2020 | 137 | 26 | 23.42% |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SLP News
- 3 days ago - Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman - GlobeNewsWire
- 10 days ago - SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 13 days ago - Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design - Business Wire
- 25 days ago - Simulations Plus: Still Positioned For FDA In‑Silico Trend Despite Near‑Term Headwinds - Seeking Alpha
- 27 days ago - Simulations Plus Sees Weaker Demand Persist, Outlook Softens - Benzinga
- 27 days ago - Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 27 days ago - Simulations Plus, Inc. (SLP) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 27 days ago - Simulations Plus Invests in Clinical Development Technology Company Nurocor - Business Wire